Concepedia

Enhanced Liver Fibrosis Score Can Be Used to Predict Liver-Related Events in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis

Vijay S. Are, Raj Vuppalanchi, Eduardo Vilar‐Gómez, Naga Chalasani

Clinical Gastroenterology and Hepatology · 2020 · 40 citations · 4 references

DOIFull text

Open access

Concepts

References

4

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Indra Neil Guha, Julie Parkes, Paul Roderick et al. · Hepatology · 2007 · 740 citations · Full text

, , +16

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu et al. · Hepatology · 2019 · 389 citations

, , +17

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

Naga Chalasani, Manal F. Abdelmalek, Guadalupe García–Tsao et al. · Gastroenterology · 2019 · 344 citations · Full text

, , +17

Enhanced Liver Fibrosis Test as a Reliable Tool for Assessing Fibrosis in Nonalcoholic Fatty Liver Disease in a Clinical Setting

Luca Miele, Teresa De Michele, Giuseppe Marrone et al. · The International Journal of Biological Markers · 2017 · 35 citations · Full text

, , +17